-
Feinberg Professor Strives to Reduce Gunshot Mortality in Chicago
Mamta Swaroop, MD, associate professor of Surgery, leads the Chicago South Side Trauma First Responders Course, a free program giving Chicago community members the tools to render first aid to trauma victims.
-
TIME Lectures Highlight New Ideas and Innovations in Medical Education
The school year’s first TIME talk, a monthly lecture series at Feinberg on innovations in medical education, was dedicated to reducing gender disparities in the field of surgery.
-
HIV Infection Hijacks Intracellular Highways
A Northwestern Medicine study found the human immunodeficiency virus uses proteins called diaphanous-related formins to hijack the cytoskeleton of healthy cells.
-
Research Progresses on $3.5M HRSA Grant
Several research projects focused on addressing gaps in the medical care of diverse populations are underway at the Center for Primary Care Innovation, funded by a $3.5 million grant from the Health Resources and Services Administration.
-
Annual Driskill Day Celebrates DGP Students and Faculty
At Driskill Day, students, alumni and faculty gathered to showcase research and celebrate excellence throughout the Driskill Graduate Program in Life Sciences.
-
Kalb Named Inaugural Les Turner ALS Research and Patient Center Director
Robert Kalb, MD, has been named to lead the Les Turner ALS Research and Patient Center at Northwestern Medicine, as the center’s inaugural director.
-
Incoming PhD Students Arrive on Campus
Feinberg recently welcomed dozens of new PhD students to campus, including students in the Driskill Graduate Program in the Life Sciences and the Northwestern University Interdepartmental Neuroscience Program.
-
Treating the Whole Person
Meet Jeffrey Linder, ’97 MD, MPH, Feinberg’s chief of General Internal Medicine and Geriatrics in the Department of Medicine.
-
Scientists Discover Novel Mechanism Underlying ALS and Related Dementia
A study has identified a new mechanism for how a gene mutation leads to the death of neurons in amyotrophic lateral sclerosis and a related form of dementia.
-
Advancing Discovery Through Cutting-Edge Genomic Technologies
Xinkun Wang, PhD, director of the NUSeq Core Facility, supports the research of scientists throughout the medical school with the latest genomic technologies, including next-generation sequencing.
-
Brain Rewiring in Parkinson’s Disease May Contribute to Abnormal Movement
A study published in Neuron suggests the brain’s own compensatory mechanisms contribute to the debilitating motor symptoms of Parkinson’s disease.
-
Pharmacogenomics for All
Northwestern Medicine investigators are on a mission to bring precision medicine to African-Americans.
-
Genomic Analysis Offers Insights into Cause of Wilms Tumor
A comprehensive genomic analysis of the most common kidney cancer in children – found genetic mutations involving two distinct processes, potentially providing new opportunities for future treatments.
-
Scientists Discover Key Cellular Mechanism Underlying Parkinson’s Disease
The major features of Parkinson’s disease have been linked to a toxic cascade beginning with oxidized dopamine, providing a possible therapeutic pathway.
-
Scientists Discover Mechanism Behind ‘Paused’ Genes
Northwestern Medicine research has explained the mechanism behind ‘pauses’ in transcription, which has implications for future cancer therapies.
-
New Leadership Named for Medical Scientist Training Program
Hossein Ardehali, MD, PhD, has been named the new director of Feinberg’s Medical Scientist Training Program; Melissa Brown, PhD, has been named associate director of advising and Xunrong Luo, MD, PhD, the associate director of admissions for the program.
-
Expanded Genetic Counseling Program Now Second-largest in the US
The Graduate Program in Genetic Counseling expanded from 14 to 20 students per class, preparing graduates for careers in various genetic counseling fields, including clinical, industry, research and public policy.
-
Going With the Ion Flow
Northwestern Medicine scientists are diving deep into the structure and function of ion channels to inform new therapies.
-
Trial Shows Drug Rapidly Reverses Blood Thinner’s Effects
The drug idarucizumab rapidly reversed the anticoagulant effects of the blood-thinner dabigatran in emergency situations, according to a recent phase III clinical trial.
-
Symposium Highlights Opportunities for Graduate Students and Postdoctoral Fellows
Graduate students and postdoctoral fellows in the biomedical field gathered for an all-day symposium dedicated to showcasing research and exploring career options.
